Dariohealth Corp. (NASDAQ:DRIO)

LabStyle Innovations Corp. is exploiting a new proprietary technology that is seeking to bring laboratory testing capabilities to consumers in a distinctive, easy to use and affordable way through the use of smartphones such as iPhones. We are initially applying our technology to address the diabetic self-monitoring of blood glucose (SMBG). Our first product, DarioTM, is a fully integrated, all-in-one SMBG device consisting of a lancet to obtain a blood sample, disposable test strip cartridge and a glucose reader adaptor to hold the strip and interface with the smartphone, combined with a smartphone application and internet-based data services. Roughly the size of a pack of gum, we believe that Dario has the potential to replace stand alone glucose meters and their kits (lancing , lancets and strips vials) which are the current market standard, most of which have the necessary testing components separated from one another in what we believe is a cumbersome design. Moreover, all but a few glucometers lack an interface with a smartphone, and none will have the software applications associated with Dario, each of which we believe will distinguish Dario as an alternative in the marketplace.